AU2002338753A1 - Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes - Google Patents

Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes

Info

Publication number
AU2002338753A1
AU2002338753A1 AU2002338753A AU2002338753A AU2002338753A1 AU 2002338753 A1 AU2002338753 A1 AU 2002338753A1 AU 2002338753 A AU2002338753 A AU 2002338753A AU 2002338753 A AU2002338753 A AU 2002338753A AU 2002338753 A1 AU2002338753 A1 AU 2002338753A1
Authority
AU
Australia
Prior art keywords
alpha
pharmaceutical composition
treating diabetes
glucosidase inhibitor
thiazolidinedione derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002338753A
Inventor
Gerard Botton
Didier Mesangeau
Gerard Moinet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002338753A1 publication Critical patent/AU2002338753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002338753A 2001-12-03 2002-09-21 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes Abandoned AU2002338753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115602A FR2832930A1 (en) 2001-12-03 2001-12-03 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
FR01/15602 2001-12-03
PCT/EP2002/010633 WO2003047627A1 (en) 2001-12-03 2002-09-21 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes

Publications (1)

Publication Number Publication Date
AU2002338753A1 true AU2002338753A1 (en) 2003-06-17

Family

ID=8870050

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002338753A Abandoned AU2002338753A1 (en) 2001-12-03 2002-09-21 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes

Country Status (4)

Country Link
AU (1) AU2002338753A1 (en)
FR (1) FR2832930A1 (en)
TW (1) TW200300682A (en)
WO (1) WO2003047627A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK179499A3 (en) * 1997-06-18 2000-11-07 Smithkline Beecham Plc The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
FR2832930A1 (en) 2003-06-06
TW200300682A (en) 2003-06-16
WO2003047627A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002354801A1 (en) Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
AU2001231104A1 (en) Methods for treating diabetes
AU2003266058A1 (en) Antimicrobial composition and method for use
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003283216A1 (en) Combination treatment using exendin-4 and thiazolidinediones
AU2003234929A1 (en) Therapeutic agent for diabetes
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
HUP0301830A3 (en) Pharmaceutical composition containing a combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2003217832A1 (en) Catheter for treating vulnerable plaque
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002322623A1 (en) Methods and compositions for treating diabetes mellitis
AU2003280393A1 (en) Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors
AU2002338753A1 (en) Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes
AU2002251541A1 (en) Apparatus and assembly for administering antimicrobial agent
AU2003282231A1 (en) Antiproliferative 2-(heteroaryl)-aminothiazole compounds, pharmaceutical compositions and methods for their use
AU2002350563A1 (en) Pharmaceutical composition comprising a glitazone and a thiazolidinedione derivative, and use thereof for treating diabetes
AU2003267848A1 (en) Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
AU2003291461A1 (en) Compositions for diabetes treatment and prophylaxis
PL369854A1 (en) Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
AU2003235434A1 (en) Use of a photosensitising compound for the preparation of a pharmaceutical composition for treating of burns, and a method of treating burns

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase